Company profile LIXT

Lixte Biotechnology Holdings Inc
lixte biotechnology holdings, inc. (lixte) is a clinical-stage public (lixt) pharmaceutical company dedicated to discovering drugs for more effective treatments for cancer. lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. the current drug portfolio includes inhibitors of protein phos...phatases that are critical to cell division and dna damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation. the phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general as well as radiation therapy making them potentially useful for the treatment of many, if not all, cancers in combination with existing standard chemotherapy regimens and the evolving targeted cytotoxic therapies of personalized cancer medicine. the lead compound lb-100 is in phase i trial and has the potential to be first-in-class. the deacetylase in Show More
Quarter analysis & expected interestLast update: February 09 2024 17:49:50.

After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0.
Lixte Biotechnology Holdings expected interest is significantly lower compared to same quarter last year (-75.4%) but similar to previous quarter.

YearQ1Q2Q3Q4
201977
30
-61.0% QoQ
141
370.0% QoQ
137
-2.8% QoQ
2020 22
-71.4% YoY -83.9% QoQ
0
-100.0% YoY -100.0% QoQ
104
-26.2% YoY inf% QoQ
91
-33.6% YoY -12.5% QoQ
2021 133
504.5% YoY 46.2% QoQ
105
inf% YoY -21.1% QoQ
145
39.4% YoY 38.1% QoQ
118
29.7% YoY -18.6% QoQ
2022 85
-36.1% YoY -28.0% QoQ
105
0.0% YoY 23.5% QoQ
57
-60.7% YoY -45.7% QoQ
0
-100.0% YoY -100.0% QoQ
2023 207
143.5% YoY inf% QoQ
24
-77.1% YoY -88.4% QoQ
57
0.0% YoY 137.5% QoQ
45
inf% YoY -21.1% QoQ
2024 22
-89.4% YoY -51.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Lixte Biotechnology Holdings search interestLast update: February 09 2024 17:49:50.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:49:54.

The average 5 years interest of Lixte Biotechnology Holdings was 6.53 per week.
The last year interest of Lixte Biotechnology Holdings compared to the last 5 years has changed by -7.5%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -18.38%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:50:00.

After 39 days of this quarter the interest is at 29.0. Based on that we can calculate that during remaining 52 days it will total up to 68.0.
Lixte Biotechnology expected interest is significantly lower compared to same quarter last year (-59.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
201973
27
-63.0% QoQ
94
248.1% QoQ
159
69.1% QoQ
2020 151
106.8% YoY -5.0% QoQ
72
166.7% YoY -52.3% QoQ
160
70.2% YoY 122.2% QoQ
206
29.6% YoY 28.8% QoQ
2021 203
34.4% YoY -1.5% QoQ
24
-66.7% YoY -88.2% QoQ
131
-18.1% YoY 445.8% QoQ
99
-51.9% YoY -24.4% QoQ
2022 257
26.6% YoY 159.6% QoQ
72
200.0% YoY -72.0% QoQ
91
-30.5% YoY 26.4% QoQ
67
-32.3% YoY -26.4% QoQ
2023 166
-35.4% YoY 147.8% QoQ
101
40.3% YoY -39.2% QoQ
183
101.1% YoY 81.2% QoQ
99
47.8% YoY -45.9% QoQ
2024 29
-82.5% YoY -70.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Lixte Biotechnology search interestLast update: February 09 2024 17:49:59.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:50:01.

The average 5 years interest of Lixte Biotechnology was 9.44 per week.
The last year interest of Lixte Biotechnology compared to the last 5 years has changed by 3.28%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 22.8%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:50:08.

After 39 days of this quarter the interest is at 48.0. Based on that we can calculate that during remaining 52 days it will total up to 112.0.
Lixte Biotechnology stock expected interest is significantly higher compared to previous quarter (+124.0%) but similar to same quarter last year.

YearQ1Q2Q3Q4
20190
228
inf% QoQ
158
-30.7% QoQ
0
-100.0% QoQ
2020 145
inf% YoY inf% QoQ
92
-59.6% YoY -36.6% QoQ
104
-34.2% YoY 13.0% QoQ
149
inf% YoY 43.3% QoQ
2021 120
-17.2% YoY -19.5% QoQ
120
30.4% YoY 0.0% QoQ
151
45.2% YoY 25.8% QoQ
154
3.4% YoY 2.0% QoQ
2022 146
21.7% YoY -5.2% QoQ
170
41.7% YoY 16.4% QoQ
88
-41.7% YoY -48.2% QoQ
86
-44.2% YoY -2.3% QoQ
2023 156
6.8% YoY 81.4% QoQ
97
-42.9% YoY -37.8% QoQ
86
-2.3% YoY -11.3% QoQ
50
-41.9% YoY -41.9% QoQ
2024 48
-69.2% YoY -4.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Lixte Biotechnology stock search interestLast update: February 09 2024 17:50:07.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:50:09.

The average 5 years interest of Lixte Biotechnology stock was 9.0 per week.
The last year interest of Lixte Biotechnology stock compared to the last 5 years has changed by -34.78%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -34.04%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for protein phosphatases inhibitors to provide analysis

Correlation between past revenue and protein phosphatases inhibitors search interest

There is not enough data for protein phosphatases inhibitors to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for protein phosphatases inhibitors to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for LB-100 series to provide analysis

Correlation between past revenue and LB-100 series search interest

There is not enough data for LB-100 series to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for LB-100 series to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for LB-200 series to provide analysis

Correlation between past revenue and LB-200 series search interest

There is not enough data for LB-200 series to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for LB-200 series to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:50:16.

After 39 days of this quarter the interest is at 31.0. Based on that we can calculate that during remaining 52 days it will total up to 72.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201996
143
49.0% QoQ
101
-29.4% QoQ
115
13.9% QoQ
2020 78
-18.8% YoY -32.2% QoQ
31
-78.3% YoY -60.3% QoQ
56
-44.6% YoY 80.6% QoQ
63
-45.2% YoY 12.5% QoQ
2021 88
12.8% YoY 39.7% QoQ
80
158.1% YoY -9.1% QoQ
185
230.4% YoY 131.2% QoQ
105
66.7% YoY -43.2% QoQ
2022 80
-9.1% YoY -23.8% QoQ
45
-43.8% YoY -43.8% QoQ
91
-50.8% YoY 102.2% QoQ
97
-7.6% YoY 6.6% QoQ
2023 93
16.2% YoY -4.1% QoQ
80
77.8% YoY -14.0% QoQ
68
-25.3% YoY -15.0% QoQ
111
14.4% YoY 63.2% QoQ
2024 31
-66.7% YoY -72.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Gaucher's disease search interestLast update: February 09 2024 17:50:15.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:50:18.

The average 5 years interest of Gaucher's disease was 7.04 per week.
The last year interest of Gaucher's disease compared to the last 5 years has changed by 2.41%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -24.42%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:50:24.

After 39 days of this quarter the interest is at 228.0. Based on that we can calculate that during remaining 52 days it will total up to 532.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019205
215
4.9% QoQ
240
11.6% QoQ
273
13.8% QoQ
2020 262
27.8% YoY -4.0% QoQ
246
14.4% YoY -6.1% QoQ
200
-16.7% YoY -18.7% QoQ
255
-6.6% YoY 27.5% QoQ
2021 202
-22.9% YoY -20.8% QoQ
310
26.0% YoY 53.5% QoQ
211
5.5% YoY -31.9% QoQ
276
8.2% YoY 30.8% QoQ
2022 370
83.2% YoY 34.1% QoQ
305
-1.6% YoY -17.6% QoQ
279
32.2% YoY -8.5% QoQ
314
13.8% YoY 12.5% QoQ
2023 469
26.8% YoY 49.4% QoQ
394
29.2% YoY -16.0% QoQ
333
19.4% YoY -15.5% QoQ
433
37.9% YoY 30.0% QoQ
2024 228
-51.4% YoY -47.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and neurodegenerative diseases search interestLast update: February 09 2024 17:50:23.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:50:25.

The average 5 years interest of neurodegenerative diseases was 23.07 per week.
The last year interest of neurodegenerative diseases compared to the last 5 years has changed by 36.8%.
The interest for neurodegenerative diseases is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 56.86%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for chronic hereditary diseases to provide analysis

Correlation between past revenue and chronic hereditary diseases search interest

There is not enough data for chronic hereditary diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for chronic hereditary diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for LIXT
Earnings date: 2024-03-27 Before open
Company name: Lixte Biotechnology Holdings Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T21:18:00Z

GlobeNewswire
LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update

2026-04-13T12:00:00Z

GlobeNewswire
Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference

2026-03-31T19:45:00Z

GlobeNewswire
LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year

2026-02-18T13:00:00Z

GlobeNewswire
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary

2026-01-21T13:00:00Z

GlobeNewswire
DE LA SOUL-LED "GOOD HEALTH SUMMIT" LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE

2026-01-20T13:00:00Z

GlobeNewswire
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29

2026-01-13T13:30:00Z

GlobeNewswire
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.

2025-12-23T13:00:00Z

GlobeNewswire
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial

2025-12-22T21:48:38Z

GlobeNewswire
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering

2025-12-18T14:00:00Z

GlobeNewswire
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

2025-12-08T13:30:00Z

AccessWire
LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities

2025-12-03T16:00:00Z

AccessWire
LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology

2025-12-03T13:00:00Z

AccessWire
LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers

2025-11-25T13:30:00Z

GlobeNewswire
LIXTE Biotechnology Acquires Liora Technologies' Proprietary Proton Therapy Platform for Cancer Treatment

2025-10-29T12:00:00Z

GlobeNewswire
LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3